EXHIBIT 99.01
DEL GLOBAL TECHNOLOGIES ANNOUNCES SUPPLY AGREEMENTS WITH NOVATION
DEL MEDICAL IMAGING INKS DEALS WITH MAJOR NATIONAL GROUP PURCHASING ORGANIZATION
VALHALLA, NY - JULY 28, 2005 - DEL GLOBAL TECHNOLOGIES CORP. (DGTC) ("Del
Global" or "the Company") today announced that its subsidiary, Del Medical
Imaging Corporation ("Del Medical"), a leading manufacturer of general purpose
radiographic imaging systems, has signed two agreements with Novation, the
supply company of VHA Inc. and the University HealthSystem Consortium (UHC).
Del Medical has been awarded a dual-source agreement for general radiology
(non-acute care) equipment and a multi-source agreement for digital radiography
systems and accessories. Through these three-year agreements, VHA and UHC member
facilities will be able to access discounted pricing on Del Medical radiographic
and digital radiography systems for all of their hospital, outpatient clinic,
and medical center sites.
Based in Irving, Texas, Novation was established in January 1998 through a
combination of the supply programs of VHA and UHC, two national health care
alliances. Novation serves the purchasing needs of more than 2,500 members and
affiliates of VHA and UHC. These organizations used Novation contracts to
purchase more than $23 billion in supplies in 2004.
Novation awarded the contracts through its public competitive bid process, with
input from member surveys, and member-based Novation Diagnostic Imaging, Capital
and Facilities, and Anesthesia Councils, and the Novation Diagnostic Imaging
Capital Equipment Task Force.
"We are very excited about this relationship with Novation, as well as the
opportunity to offer what we believe is the gold standard in general
radiographic and digital radiography equipment to VHA and UHC members
nationwide," said Scott Loehrke, Vice President, Sales and Marketing at Del
Medical. "We believe the opportunity for Novation customers to purchase product
from our extensive line will be mutually beneficial."
Walter F. Schneider, President and Chief Executive Officer of Del Global,
commented, "Del Medical's business continues to grow as hospitals look for more
cost-effective alternatives for their general radiographic needs. DEL Medical's
product lines are known for their reliability and high quality diagnostic
imaging capabilities. The addition of a market leading technology in the Epex DR
product line completes Del Medical's offerings into the radiographic
marketplace."
All of Del Medical's hospital configured radiographic systems are fully
upgradeable to provide digital imaging capabilities. The Company sells its
products worldwide through independent distributors.
ABOUT DEL GLOBAL TECHNOLOGIES
Del Global Technologies Corp. is primarily engaged in the design, manufacture
and marketing of cost-effective medical imaging and diagnostic systems
consisting of stationary and portable x-ray systems, radiographic/fluoroscopic
systems, dental imaging systems and proprietary high-voltage power conversion
subsystems for medical and other critical industrial applications. Through its
RFI subsidiary, Del Global manufactures electronic filters, high voltage
capacitors, pulse modulators, transformers and reactors, and a variety of other
products designed for industrial, medical, military and other commercial
applications.
Statements about future results made in this release may constitute
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These statements are based on current
expectations and the current economic environment. Del Global cautions that
these statements are not guarantees of future performance. These statements
involve a number of risks and uncertainties that are difficult to predict,
including, but not limited to: the ability of Del Global to implement its
business plan; the ability of Del Medical to deliver on all orders related to
its supply agreement with Novation; retention of management; changing industry
and competitive conditions; obtaining anticipated operating efficiencies;
securing necessary capital facilities; favorable determinations in various legal
matters; market and operating risks from foreign currency exchange exposures;
and favorable general economic conditions. Actual results could differ
materially from those expressed or implied in the forward-looking statements.
Important assumptions and other important factors that could cause actual
results to differ materially from those in the forward-looking statements are
specified in the Company's filings with the Securities and Exchange Commission.
CONTACT:
Del Global Technologies Corp.
Walter F. Schneider, President & Chief Executive Officer
Mark Koch, Principal Accounting Officer
914-686-3650
or
Investor Relations:
The Equity Group Inc.
Devin Sullivan, 212-836-9608
Adam Prior, 212-836-9606
